We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The government and NHS have accepted the recommendation from the Independent Medicines and Medical Devices Safety Review to pause the use of vaginally inserted surgical mesh for stress urinary incontinence.
The final report from the Scottish independent review of the use, safety and efficacy of transvaginal mesh implants.
An interim report from the Scottish independent review of the use, safety and efficacy of transvaginal mesh implants.
This analysis relates to patients who have had mesh procedures for SUI and urogynaecological prolapse since 2008.
Manufactured by C.R. Bard (Becton, Dickinson and Company (BD)) – surgical mesh for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) is being withdrawn from hospitals and distribution centres.
A Medical Device Alert has been issued on C.R. Bard removing all surgical mesh for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) from the market.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).